<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Xiao</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2017</year>). 
  <article-title>Screening of FDA-approved drugs for inhibitors of Japanese encephalitis virus infection</article-title>. 
  <source>J. Virol.</source>
  <volume>91</volume>, 
  <fpage>e01055</fpage>â€“
  <lpage>e01017</lpage>. 
  <pub-id pub-id-type="doi">10.1128/JVI.01055-17</pub-id>
  <?supplied-pmid 28814523?>
  <pub-id pub-id-type="pmid">28814523</pub-id>
 </mixed-citation>
</ref>
